[1] Backhed F,Ley RE,Sonnenburg JL,et al. Host-bacterial mutualism in the human intestine. Science,2005,307:1915-1920.
[2] Hollister EB,Gao C,Versalovic J. Compositional and functional features of the gastrointestinal microbiome and their effects on human health. Gastroenterology,2014,146: 1449-1458.
[3] Manichanh C,Rigottier-Gois L,Bonnaud E,et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut,2006,55: 205-211.
[4] Ley RE, Turnbaugh PJ, Klein S, et al. Microbial ecology: human gut microbes associated with obesity. Nature,2006,444: 1022-1023.
[5] Lozupone CA, Stombaugh JI, Gordon JI, et al. Diversity,stability and resilience of the human gut microbiota. Nature,2012,489,220-230.
[6] Kalliomaki M, Collado MC, Salminen S, et al. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr, 2008,87: 534-538.
[7] Wong JM, de Souza R, Kendall CW, et al. Colonic health: Fermentation and short chain fatty acids. J Clin Gastroenterol,2006,40: 235-243.
[8] Miele L,Valenza V,La Torre G,et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.Hepatology,2009,49: 1877-1887.
[9] Wigg AJ,Roberts-Thomson IC,Dymock RB,et al. The role of small intestinal bacterial overgrowth,intestinal permeability,endotoxaemia,and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut,2001,48: 206-211.
[10] Ruiz AG,Casafont F,Crespo J,et al. Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis. Obes Surg, 2007,17: 1374-1380.
[11] Alisi A,Manco M,Devito R,et al. Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr,2010,50: 645-649.
[12] Rivera CA,Adegboyega P,van Rooijen N,et al. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J Hepatol, 2007,47: 571-579.
[13] Dawes E, Foster SM. The formation of ethanol in Escherichia coli. Biochim. Biophys,1956, Acta 22:253-265.
[14] Nair S,Cope K,Terence RH, et al. Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis. Am J Gastroenterol,2001, 96:1200-1204.
[15] Zhu L, Baker SS, Gill C, et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology,2013,57: 601-609.
[16] He X,Ji G,Jia W,Li H. Gut microbiota and nonalcoholic fatty liver disease: insights on mechanism and application of metabolomics. Int J Mol Sci,2016,17:300.
[17] Kobyliak N,Virchenko O,Falalyeyeva T. Pathophysiological role of host microbiota in the development of obesity. Nutr J,2015,15:43.
[18] Vance DE. Role of phosphatidylcholine biosynthesis in the regulation of lipoprotein homeostasis. Curr Opin Lipidol,2008,19: 229-234.
[19] Buchman AL,Dubin MD,Moukarzel AA,et al. Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation. Hepatology,1995,22: 1399-1403.
[20] Musso G,Gambino R, Cassader M. Obesity,diabetes,and gut microbiota the hygiene hypothesis expanded. Diabetes Care,2010 ,33: 2277-2284.
[21] Rivera LR, Leung C, Pustovit RV, et al. Damage to enteric neurons occurs in mice that develop fatty liver disease but not diabetes in response to a high-fat diet.Neurogastroenterol Motil,2014, 26: 1188-1199.
[22] Jalanka-Tuovinen J, Saloiarvi J, Salonen A, et al. Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome. Gut, 2014,63: 1737-1745.
[23] Paik YH,Schwabe RF,Bataller R,Russo MP,Jobin C,Brenner DA. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology,2003,37: 1043-1055.
[24] Wong VW,Tse CH,Lam TT,et al. Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis--a longitudinal study. PLoS One,2013,8:e62885.
[25] Ma YY,Li L,Yu CH,et al. Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis. World J Gastroenterol,2013,19:6911-6918.
[26] Turnbaugh PJ,Ley RE,Mahowald MA,et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature,2006,444: 1027-1031. |
